Contact Us    855-RIA-PLAN (855-742-7526)

CPSR: Capstar Special Purpose Acquisition Corp Stock

By | July 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) n/a
Book Value / Share n/a
Price / Book n/a
NCAV ($M) 0.00
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets n/a
Assets n/a
Liabilities n/a
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income n/a
Net Income n/a

Cash Flow Statement (mra) ($M)
Cash From Operations n/a
Cash from Investing n/a
Cash from Financing n/a

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
01-21 13G Ssd2, Llc 18.22
01-21 13D HPSO SPV Ltd 16.90
01-21 13D PureTech Health LLC 23.60
09-20 13G Citadel Advisors Llc 5.90
02-16 13G Glazer Capital, Llc 5.50 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-11-24 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 2)
2021-11-16 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPO
2021-09-22 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ¨
2021-08-16 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PU
2021-07-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2021-07-08 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ¨ TRANSITION REPO
2021-03-31 10-K Annual Report – FORM 10-K

(click for more detail)

Similar Companies
BHC – BauschHealth?Companies?Inc. BHVN – Biohaven Pharmaceutical Holding Co Ltd
BMY – Bristol-Myers Squibb Co CPSR.U – Capstar Special Purpose Acquisition Corp. Units, each consisting of one share of Class A Common Stoc
CTLT – Catalent Inc


Financial data and stock pages provided by
Fintel.io





2018/07/06
> Back to All Posts